Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04173325
Title Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Augusta University
Indications

lung small cell carcinoma

Therapies

Nivolumab

Irinotecan + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.